Document Detail


Long-Term Safety and Efficacy of Fluticasone/Formoterol Combination Therapy in Asthma.
MedLine Citation:
PMID:  23098325     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Background: The long-term safety of a new asthma therapy combining fluticasone propionate and formoterol fumarate (fluticasone/formoterol; flutiform(®)) was assessed. Method: In an open-label study, mild to moderate-severe asthmatics (≥12 years; N=472) were treated twice daily with fluticasone/formoterol 100/10 μg (n=224) or 250/10 μg (n=248) for 6 months (n=256) or 12 months (n=216). The primary and secondary objectives were the long-term safety and efficacy of fluticasone/formoterol, respectively. Results: In total, 413 (87.5%) patients completed the study (of which 175 participated for 12 months). Adverse events (AEs) were reported by 174 patients (36.9%): 67 (29.9%) in the 100/10 μg group and 107 (43.1%) in the 250/10 μg group. The most common AEs (>2%) were nasopharyngitis, dyspnea, pharyngitis, and headache; the majority were mild to moderate. Only 18 (3.8%) patients reported AEs considered study drug-related. Five patients per group experienced 12 serious AEs; none was study medication-related. Asthma exacerbations were reported by 53 patients (11.2%): 46 mild to moderate and nine severe. Clinical laboratory tests and vital signs showed no abnormal trends or clinically important or dose-response-related changes. The efficacy analyses showed statistically significant improvements at every time point throughout the study period at both doses. Conclusion: Fluticasone/formoterol had a good safety and efficacy profile over the 6- and 12-month study periods.
Authors:
Adel H Mansur; Kirsten Kaiser
Related Documents :
21242545 - Use of laryngeal mask airway in pediatric adenotonsillectomy.
518185 - The prosthetic (teflon) central aortopulmonary shunt for cyanotic infants less than thr...
9429285 - Acute and chronic complications after implantation of a transjugular intrahepatic porto...
7609195 - Priapism in children with sickle cell disease.
6190255 - Are axillofemoral bypass grafts worthwhile? a 10-year review.
22009525 - Evaluation of the efficacy and safety of intravenous ciprofloxacin versus meropenem in ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-25
Journal Detail:
Title:  Journal of aerosol medicine and pulmonary drug delivery     Volume:  -     ISSN:  1941-2703     ISO Abbreviation:  J Aerosol Med Pulm Drug Deliv     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101475057     Medline TA:  J Aerosol Med Pulm Drug Deliv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 Chest Research Institute, Birmingham Heartlands Hospital , Birmingham B9 5SS, United Kingdom .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis: A Critical and Systematic...
Next Document:  Quantitative Analysis and Design of a Spray Aerosol Inhaler. Part 2: Improvements in Mouthpiece Perf...